Study on preparation and application performance of blue sky rare earth light storage and emission material

Under reduction atmosphere, a blue sky rare earth silicate light storage and emission material was prepared by high temperature solid phase synthesis. The best constituent ratio of this material was determined through orthogonal experiment, and its excitation and emission spectra and X-ray diffraction patterns were measured. And a comparative study was conducted on its application properties.     

声发射测量原岩应力研究现状及进展

综述了声发射测量原岩应力的国内外研究现状和目前所存在的主要问题，结合信号处理小波分析方法的研究成果，说明了将小波分析引入到原岩应力测量的重要性，最后提出了基于小波分析的综合研究方法作为声发射测量原岩应力的进一步研究方向。     

浅析矿山机电在现代煤矿企业中应用

现代煤矿企业在扩大生产规模的过程中,为了响应国家节能减排的号召,采取了一些较为先进的技术,为企业的可持续发展提供了重要地保障。由于一些客观因素的影响,矿山机电在现代煤矿企业实际的应用中依然存在着一些突出的问题,制约了企业整体的发展。本文将对矿山机电在现代煤矿企业中的应用现状等方面展开论述。     

Soil and water quality assessment along the Red Sea coast,Egypt

The paper reports an assessment of the soil and water in the coastal strip between Marsa Alam and Shalateen at the southern part of the Red Sea coast of Egypt. There is limited potential for agricultural development. There is a need for water re-use and some potential for tourism.     

Removal of Lissamine Red From Wastewater Using Waste Materials

Feasibility of a waste material, flyash, as a material for purification of wastewater containing Lissamine Red has been studied. Effects of time and concentration, temperature and pH on the removal of the dye have been studied. Lower concentrations favour the uptake of dye from water and the maximum removal was observed at a dye concentration of 20 mgL m 1 , 30°C, pH of 7 and adsorbent particle size of 53 µm. Dynamics of the uptake was studied using Lagergren's equation. The mass transfer coefficient was found to be 0.05 cmmin m 1 at a concentration of 20 mgL m 1 , 30°C and 53 µm particle size.     

聚乙烯格网阻风、消泡的研究与应用

当废水中有表面活性剂成分时,通常采用消泡剂消除好氧曝气池液面聚集的泡沫,但消泡效果差,同时会增加成本和污染物的量。试验发现超小尺寸格网具有阻风、割裂泡沫的功能,采用超小尺寸格网覆盖好氧曝气池池面,能够彻底解决泡沫乱飞的危害,每年可节省消泡剂费用70万元,人工成本20万元,生化出水CODCr的质量浓度比投加消泡剂时下降15～25 mg/L,而且易于管理。     

C60-卤代苯吡咯烷的合成及光谱表征

合成了一种新的C60-卤代苯吡咯烷衍生物1,以1HNMR、13CNMR、FT-IR、FAB-MS和UV进行了结构表征.测量其在甲苯溶液中的荧光发射光谱,并在此最大发射波长下测得其荧光寿命为5.26ns,而C60在室温的荧光寿命大约是1.2ns。说明C60-卤代苯吡咯烷(1)在激光激发下发生了加成基团苯环与母体C60之间的分子内能量转移和电荷传递,有可能产生长寿命的电荷分离态。理论计算化合物1的电子结构和前线轨道进一步验证了上述结果。     

PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic Review

Breast cancer (BC) is a heterogeneous malignancy that still represents the second cause of cancer-related death among women worldwide. Due to the heterogeneity of BC, the correct identification of valuable biomarkers able to predict tumor biology and the best treatment approaches are still far from clear. Although molecular imaging with positron emission tomography/computed tomography (PET/CT) has improved the characterization of BC, these methods are not free from drawbacks. In recent years, radiomics and artificial intelligence (AI) have been playing an important role in the detection of several features normally unseen by the human eye in medical images. The present review provides a summary of the current status of radiomics and AI in different clinical settings of BC. A systematic search of PubMed, Web of Science and Scopus was conducted, including all articles published in English that explored radiomics and AI analyses of PET/CT images in BC. Several studies have demonstrated the potential role of such new features for the staging and prognosis as well as the assessment of biological characteristics. Radiomics and AI features appear to be promising in different clinical settings of BC, although larger prospective trials are needed to confirm and to standardize this evidence.     

PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [68Ga]Ga-NODAGA-AMBA and [44Sc]Sc-NODAGA-AMBA

Gastrin-releasing peptide receptors (GRPR) are overexpressed in prostate cancer (PCa). Since bombesin analogue aminobenzoic-acid (AMBA) binds to GRPR with high affinity, scandium-44 conjugated AMBA is a promising radiotracer in the PET diagnostics of GRPR positive tumors. Herein, the GRPR specificity of the newly synthetized [⁴⁴Sc]Sc-NODAGA-AMBA was investigated in vitro and in vivo applying PCa PC-3 xenograft. After the in-vitro assessment of receptor binding, PC-3 tumor-bearing mice were injected with [⁴⁴Sc]Sc/[⁶⁸Ga]Ga-NODAGA-AMBA (in blocking studies with bombesin) and in-vivo PET examinations were performed to determine the radiotracer uptake in standardized uptake values (SUV). ⁴⁴Sc/⁶⁸Ga-labelled NODAGA-AMBA was produced with high molar activity (approx. 20 GBq/µmoL) and excellent radiochemical purity. The in-vitro accumulation of [⁴⁴Sc]Sc-NODAGA-AMBA in PC-3 cells was approximately 25-fold higher than that of the control HaCaT cells. Relatively higher uptake was found in vitro, ex vivo, and in vivo in the same tumor with the ⁴⁴Sc-labelled probe compared to [⁶⁸Ga]Ga-NODAGA-AMBA. The GRPR specificity of [⁴⁴Sc]Sc-NODAGA-AMBA was confirmed by significantly (p ≤ 0.01) decreased %ID and SUV values in PC-3 tumors after bombesin pretreatment. The outstanding binding properties of the novel [⁴⁴Sc]Sc-NODAGA-AMBA to GRPR outlines its potential to be a valuable radiotracer in the imaging of GRPR-positive PCa.     

11C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to 18F-FDG PET/CT and Prognostic Value

Multiple myeloma (MM) is the second most common haematological malignancy and remains incurable despite therapeutic advances. ¹⁸F-FDG (FDG) PET/CT is a relevant tool MM for staging and it is the reference imaging technique for treatment evaluation. However, it has limitations, and investigation of other PET tracers is required. Preliminary results with L-methyl-[¹¹C]- methionine (MET), suggest higher sensitivity than ¹⁸F-FDG. This study aimed to compare the diagnostic accuracy and prognostic value of ¹FDG and MET in MM patients. We prospectively compared FDG and MET PET/CT for assessment of bone disease and extramedullary disease (EMD) in a series of 52 consecutive patients (8 smoldering MM, 18 newly diagnosed MM and 26 relapsed MM patients). Bone marrow (BM) uptake patterns and the detection of focal lesions (FLs) and EMD were compared. Furthermore, FDG PET parameters with known MM prognostic value were explored for both tracers, as well as total lesion MET uptake (TLMU). Median patient age was 61 years (range, 37–83 years), 54% were male, 13% of them were in stage ISS (International Staging System) III, and 31% had high-risk cytogenetics. FDG PET/CT did not detect active disease in 6 patients, while they were shown to be positive by MET PET/CT. Additionally, MET PET/CT identified a higher number of FLs than FDG in more than half of the patients (63%). For prognostication we focussed on the relapsed cohort, due to the low number of progressions in the two other cohorts. Upon using FDG PET/CT in relapsed patients, the presence of more than 3 FLs (HR 4.61, p = 0.056), more than 10 FLs (HR 5.65, p = 0.013), total metabolic tumor volume (TMTV) p50 (HR 4.91, p = 0.049) or TMTV p75 (HR 5.32, p = 0.016) were associated with adverse prognosis. In MET PET/CT analysis, TMTV p50 (HR 4.71, p = 0.056), TMTV p75 (HR 6.27, p = 0.007), TLMU p50 (HR 8.8, p = 0.04) and TLMU p75 (HR 6.3, p = 0.007) adversely affected PFS. This study confirmed the diagnostic and prognostic value of FDG in MM. In addition, it highlights that MET has higher sensitivity than FDG PET/CT for detection of myeloma lesions, including FLs. Moreover, we show, for the first time, the prognostic value of TMTV and TLMU MET PET/CT in the imaging evaluation of MM patients.